Literature DB >> 18448546

Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport.

Jason G Smith1, Aurelia Cassany, Larry Gerace, Robert Ralston, Glen R Nemerow.   

Abstract

Neutralizing antibodies are commonly elicited by viral infection. Most antibodies that have been characterized block early stages of virus entry that occur before membrane penetration, whereas inhibition of late stages in entry that occurs after membrane penetration has been poorly characterized. Here we provide evidence that the neutralizing antihexon monoclonal antibody 9C12 inhibits adenovirus infection by blocking microtubule-dependent translocation of the virus to the microtubule-organizing center following endosome penetration. These studies identify a previously undescribed mechanism by which neutralizing antibodies block virus infection, a situation that may be relevant for other nonenveloped viruses that use microtubule-dependent transport during cell entry.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18448546      PMCID: PMC2447115          DOI: 10.1128/JVI.00557-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Antipeptide antisera define neutralizing epitopes on the adenovirus hexon.

Authors:  C I Toogood; J Crompton; R T Hay
Journal:  J Gen Virol       Date:  1992-06       Impact factor: 3.891

Review 2.  Phage display.

Authors:  D R Burton
Journal:  Immunotechnology       Date:  1995-08

3.  Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization.

Authors:  P L Stewart; C Y Chiu; S Huang; T Muir; Y Zhao; B Chait; P Mathias; G R Nemerow
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

4.  Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.

Authors:  H Gahéry-Ségard; F Farace; D Godfrin; J Gaston; R Lengagne; T Tursz; P Boulanger; J G Guillet
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Stepwise dismantling of adenovirus 2 during entry into cells.

Authors:  U F Greber; M Willetts; P Webster; A Helenius
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

6.  Antigenic sites on the receptor-binding domain of human adenovirus type 2 fiber.

Authors:  P Fender; A H Kidd; R Brebant; M Oberg; E Drouet; J Chroboczek
Journal:  Virology       Date:  1995-12-01       Impact factor: 3.616

7.  Antibody-mediated uncoating of adenovirus in vitro.

Authors:  E Everitt; A de Luca; Y Blixt
Journal:  FEMS Microbiol Lett       Date:  1992-11-01       Impact factor: 2.742

8.  Proline 137 is critical for adenovirus protease encapsidation and activation but not enzyme activity.

Authors:  C Rancourt; H Keyvani-Amineh; S Sircar; P Labrecque; J M Weber
Journal:  Virology       Date:  1995-05-10       Impact factor: 3.616

9.  Sequence and characterization of cytoplasmic nuclear protein import factor p97.

Authors:  N C Chi; E J Adam; S A Adam
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

10.  Inhibition of cell adhesion to the virus by synthetic peptides of fiber knob of human adenovirus serotypes 2 and 3 and virus neutralisation by anti-peptide antibodies.

Authors:  H Liebermann; R Mentel; L Döhner; S Modrow; W Seidel
Journal:  Virus Res       Date:  1996-12       Impact factor: 3.303

View more
  28 in total

1.  Regulation of virus neutralization and the persistent fraction by TRIM21.

Authors:  W A McEwan; F Hauler; C R Williams; S R Bidgood; D L Mallery; R A Crowther; L C James
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

2.  Functional genetic and biophysical analyses of membrane disruption by human adenovirus.

Authors:  Crystal L Moyer; Christopher M Wiethoff; Oana Maier; Jason G Smith; Glen R Nemerow
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

3.  Cryo-electron microscopy structure of adenovirus type 2 temperature-sensitive mutant 1 reveals insight into the cell entry defect.

Authors:  Mariena Silvestry; Steffen Lindert; Jason G Smith; Oana Maier; Christopher M Wiethoff; Glen R Nemerow; Phoebe L Stewart
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

4.  Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome.

Authors:  A U Barlan; P Danthi; C M Wiethoff
Journal:  Virology       Date:  2011-02-18       Impact factor: 3.616

5.  Directed evolution of mutator adenoviruses resistant to antibody neutralization.

Authors:  Nicolle D Myers; Ksenia V Skorohodova; Anshu P Gounder; Jason G Smith
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

Review 6.  Adenovirus-triggered innate signalling pathways.

Authors:  G Fejer; M Freudenberg; U F Greber; I Gyory
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-12-23

7.  Inhibition of adenovirus replication by a trisubstituted piperazin-2-one derivative.

Authors:  Javier Sanchez-Cespedes; Crystal L Moyer; Landon R Whitby; Dale L Boger; Glen R Nemerow
Journal:  Antiviral Res       Date:  2014-06-04       Impact factor: 5.970

Review 8.  Adenovirus.

Authors:  Jason G Smith; Christopher M Wiethoff; Phoebe L Stewart; Glen R Nemerow
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

9.  Reduced infectivity of adenovirus type 5 particles and degradation of entering viral genomes associated with incomplete processing of the preterminal protein.

Authors:  Sayuri E Kato; Jasdave S Chahal; S J Flint
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

10.  AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization.

Authors:  Felix Hauler; Donna L Mallery; William A McEwan; Susanna R Bidgood; Leo C James
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.